https://www.techtarget.com/pharmalifesciences/news/366606791/Eli-Lillys-Retevmo-Helps-Non-Small-Cell-Lung-Cancer-Patients
Eli Lilly & Company recently announced updates on the Phase 2 clinical trial studying its kinase inhibitor, Retevmo, in RET fusion-positive non-small cell lung...
eli lillysmall celllung cancerretevmohelps